Developer docs
API playgroundTry for free, no card

Search company profiles

bioX

Full company profile

uuid000lsr8

Namestring
bioX
Legal namestring
bioX
Websiteurl
bioxeng.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

bioX is a privately held, integrated biotech engineering, analytical testing, and early-phase CDMO solutions provider founded in 2019 and headquartered in Salem, New Hampshire (Greater Boston Area). The company serves biotech and pharmaceutical developers — spanning cell and gene therapies (CGT), mRNA/siRNA/tRNA, monoclonal antibodies (mAb), antibody-drug conjugates (ADC), exosome therapeutics, microbiome products, ATMPs, and single-use technology (SUT) suppliers — with a vertically segmented go-to-market. Its stated core technology centers on Single-Use Technology consulting and a 14,000 sq/ft ISO-7 applications lab that supports pilot-scale manufacturing feasibility testing, comparison testing of unit operations (mixing, cell harvest, transfection/transduction, filtration, bioreactor, chromatography), and a comprehensive USP/ASTM/ISO testing suite including USP <1207> container closure, USP <665> forced extraction, USP <85> endotoxin, USP <61>/<62>/<71> bioburden, USP <788> particulate, MTBF and spallation testing, and mixing characterization.

The company's product portfolio comprises eight integrated service lines: Bio-Process Engineering and Consulting, Early Phase CDMO Services, Pilot Scale and Applications Lab, Quality Engineering and Consulting (CQV, validation, qualification), Strategic BioEngineering (owner's project management, master planning, Industry 4.0 initiatives), Manufacturing Process Improvement, Automation Strategy Development, and Consulting and Training. BioX operates under a 21CFR Part 11 and ISO 9001:2015 compliant quality management system, which qualifies it for cGMP-related regulatory submissions and PPQ support. The firm is founder-led: Mark McElligott serves as Founder, Owner, and Principal Process Engineer.

bioX makes money through project-based professional services and managed services engagements, priced on a custom quote basis with multi-year contracts. Pricing is not publicly disclosed. The go-to-market is enterprise-focused, consultative field sales targeting biotech and pharma companies, with global service delivery claimed from the Salem, NH headquarters (primary market served is North America). Marketing relies primarily on the corporate website (bioxeng.com), an email newsletter subscription, and direct quote-based inquiry, with no disclosed partnerships, channel relationships, named customers, or completed funding rounds in the input data.

Short descriptiontext

bioX is a Salem, NH-based biotech engineering, analytical testing, and early-phase CDMO services provider serving developers of cell and gene therapies, mRNA, monoclonal antibodies, ADCs, exosomes, microbiome, and ATMPs, anchored by an ISO-7 applications lab and SUT consulting expertise.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSalem, United States
HQ citystring
Salem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioprocess engineering services, analytical testing services, contract development manufacturing, single-use technology consulting, biopharma process development
Industry4 codes
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Biopharmaceutical Engineering & CDMO Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Process Engineering and Consulting Services
TypeProfessional Services
Description

Provides bio-process engineering, single-use technology consulting, quality engineering, and methods development/analytical testing services on a project basis. Revenue generated through consulting engagements, feasibility studies, and technical advisory services.

bioxeng.com
2Early Phase CDMO Services
TypeManaged Services
Description

Contract development and manufacturing organization services including tech transfer from bench to pilot scale, process optimization, regulatory submission support, and agile manufacturing capabilities. Revenue generated through project-based manufacturing and development contracts.

bioxeng.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Contact Us Today for quote - all services are custom engagements tailored to client project requirements

bioxeng.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

bioX delivers integrated Bio-Process Engineering, Analytical Testing, Process Development, and Early Phase Contract Development and Manufacturing Organization (CDMO) services for the biopharmaceutical industry. The company operates a proprietary 14,000 sq/ft ISO-7 Applications Lab that runs USP/ASTM/ISO product release, physical/mechanical, biological, and chemical testing, as well as pilot-scale manufacturing feasibility campaigns. Services span Cell Banking through DP (Drug Product) bottling for advanced therapy, RNA, monoclonal antibody, ADC, exosome, microbiome, and ATMP developers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced costs through agile manufacturing innovation
+1 more record
Product overview1 text field

bioX is a biotech engineering, analytical testing, and Contract Development and Manufacturing Organization (CDMO) solutions provider. The company offers a portfolio of integrated services including Bio-Process Engineering and Consulting, Early Phase CDMO Services, a Pilot Scale and Applications Lab, Quality Engineering and Consulting, Strategic BioEngineering Services, Manufacturing Process Improvement, Automation Strategy Development, and Consulting and Training. The services are designed to work together as a single-source solutions provider, enabling clients to move from analytical development and methods qualification through feasibility testing to detail design and early phase manufacturing.

Product and service8 records
1Bio-Process Engineering and Consulting
CategoryBio-Process Engineering and Consulting
Description

Provides bio-process engineering, single-use technology program development, process and product development, bio-process applications testing, quality engineering, and methods development/analytical testing services for biotech and pharmaceutical clients.

2Early Phase CDMO Services
CategoryContract Development and Manufacturing (CDMO)
Description

Contract Development and Manufacturing Organization services including tech transfer from bench to pilot scale, 21CFR compliant QMS for MBR and MFG compliance, in-house equipment supporting multiple manufacturing modalities and analytical testing, process optimization, regulatory submission and PPQ support, and agile manufacturing capabilities. Has a proven track record from Cell Banking through DP bottling.

3Pilot Scale and Applications Lab
CategoryAnalytical Testing and Pilot-Scale Feasibility Lab
Description

A 14,000 sq/ft ISO-7 classified applications lab providing pilot scale manufacturing feasibility testing, comparison testing of similar unit operations, hold/stability testing, container closure testing, sterility program development, MTBF testing, spallation testing, mixing characterization, forced extraction, endotoxin testing, bioburden testing, particulate testing, and autoclave services.

4Quality Engineering and Consulting
CategoryQuality Engineering and Consulting
Description

Provides commissioning, qualification and validation (CQV), quality plan and systems development, shipper and shipping qualification, equipment and automation qualification, validation master planning, and user requirement specifications development for biotech and pharma manufacturing operations.

5Strategic BioEngineering Services
CategoryStrategic Engineering and Capital Planning
Description

Provides owner's project management for capital project design and execution, project and process design lead/subject matter expertise, master planning for biotech and pharma, environmental sustainability planning, and Industry 4.0 strategic initiatives for digital transformation.

6Manufacturing Process Improvement
CategoryProcess Optimization Consulting
Description

Analyzes current manufacturing processes and identifies areas for improvement to increase efficiency and reduce costs for biopharma manufacturing clients.

7Automation Strategy Development
CategoryAutomation and Controls Consulting
Description

Develops software solutions for embedded systems and control/automation systems to ensure product reliability and efficiency in biotech manufacturing operations.

8Consulting and Training
CategoryConsulting and Training
Description

Provides comprehensive consulting and training services for process and product design, manufacturing process improvement, and technology transfer to biopharma client teams.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Danaher-owned bioprocess equipment and services supplier serving the same biotech manufacturing customers as bioX. An adjacent ecosystem participant rather than a direct CDMO competitor, but competes for SUT-related service and consulting budgets.

TypeDirect peer
Description

Biopharma-focused management and process consulting firm serving similar biotech clients on process improvement, tech transfer, and operational strategy. Most direct comparable to bioX on the consulting/engineering side rather than the CDMO side.

TypeBroad incumbent
Description

Global CDMO with substantial early-phase development and clinical manufacturing capabilities across biologics and cell/gene therapy. BioX directly competes in pilot-scale and tech-transfer work but Catalent offers far greater scale, multi-site footprint, and late-phase capacity.

TypeDirect peer
Description

Gene therapy CDMO offering process development, analytical services, and cGMP manufacturing for AAV and other viral vectors. Closely comparable to bioX on cell/gene therapy focus and pilot-to-commercial pathway.

TypeDirect peer
Description

National Resilience is a technology-focused biomanufacturing company offering end-to-end process development, analytical, and clinical manufacturing services for biologics, vaccines, and advanced therapies — directly comparable to bioX's early-phase CDMO offering.

TypeDirect peer
Description

Specialist CDMO focused on cell and gene therapy development and manufacturing, including viral vectors and plasmid DNA. Overlaps with bioX's cell/gene therapy process development and early-phase CDMO services.

TypeDirect peer
Description

Contract development and manufacturing organization providing process development, analytical services, and small- and large-molecule manufacturing — overlapping with bioX's analytical testing and pilot-scale capabilities.

TypeDirect peer
Description

Specialized CGT and biologics CDMO offering process development, analytical testing, and manufacturing for cell, gene, and viral vector therapies. Directly comparable to bioX on integrated early-phase services.

TypeBroad incumbent
Description

One of the world's largest CDMOs with deep biologics, cell, and gene therapy manufacturing capability. BioX competes at the early-phase / pilot-scale entry point; Lonza is the typical 'upstream' competitor clients eventually migrate to for commercial production.

TypeBroad incumbent
Description

Global biologics CDMO with end-to-end discovery, development, and manufacturing capabilities including mAb and recombinant protein services. Competes with bioX for early-phase work but operates at vastly larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

bioX

Biopharmaceutical Engineering & CDMO Servicesbioxeng.com

bioX is a Salem, NH-based biotech engineering, analytical testing, and early-phase CDMO services provider serving developers of cell and gene therapies, mRNA, monoclonal antibodies, ADCs, exosomes, microbiome, and ATMPs, anchored by an ISO-7 applications lab and SUT consulting expertise.

What bioX does

bioX is a privately held, integrated biotech engineering, analytical testing, and early-phase CDMO solutions provider founded in 2019 and headquartered in Salem, New Hampshire (Greater Boston Area). The company serves biotech and pharmaceutical developers — spanning cell and gene therapies (CGT), mRNA/siRNA/tRNA, monoclonal antibodies (mAb), antibody-drug conjugates (ADC), exosome therapeutics, microbiome products, ATMPs, and single-use technology (SUT) suppliers — with a vertically segmented go-to-market. Its stated core technology centers on Single-Use Technology consulting and a 14,000 sq/ft ISO-7 applications lab that supports pilot-scale manufacturing feasibility testing, comparison testing of unit operations (mixing, cell harvest, transfection/transduction, filtration, bioreactor, chromatography), and a comprehensive USP/ASTM/ISO testing suite including USP <1207> container closure, USP <665> forced extraction, USP <85> endotoxin, USP <61>/<62>/<71> bioburden, USP <788> particulate, MTBF and spallation testing, and mixing characterization.

The company's product portfolio comprises eight integrated service lines: Bio-Process Engineering and Consulting, Early Phase CDMO Services, Pilot Scale and Applications Lab, Quality Engineering and Consulting (CQV, validation, qualification), Strategic BioEngineering (owner's project management, master planning, Industry 4.0 initiatives), Manufacturing Process Improvement, Automation Strategy Development, and Consulting and Training. BioX operates under a 21CFR Part 11 and ISO 9001:2015 compliant quality management system, which qualifies it for cGMP-related regulatory submissions and PPQ support. The firm is founder-led: Mark McElligott serves as Founder, Owner, and Principal Process Engineer.

bioX makes money through project-based professional services and managed services engagements, priced on a custom quote basis with multi-year contracts. Pricing is not publicly disclosed. The go-to-market is enterprise-focused, consultative field sales targeting biotech and pharma companies, with global service delivery claimed from the Salem, NH headquarters (primary market served is North America). Marketing relies primarily on the corporate website (bioxeng.com), an email newsletter subscription, and direct quote-based inquiry, with no disclosed partnerships, channel relationships, named customers, or completed funding rounds in the input data.

bioX firmographics

Firmographics
Name
bioX
Legal name
bioX
Website
https://bioxeng.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
bioX is a Salem, NH-based biotech engineering, analytical testing, and early-phase CDMO services provider serving developers of cell and gene therapies, mRNA, monoclonal antibodies, ADCs, exosomes, microbiome, and ATMPs, anchored by an ISO-7 applications lab and SUT consulting expertise.
Ownership category
akta.pro rank

bioX industry classification

Industry
Product category
Biopharmaceutical Engineering & CDMO Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical Preparation Manufacturing (325412)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Bioprocess engineering services
  • Analytical testing services
  • Contract development manufacturing
  • Single-use technology consulting
  • Biopharma process development

Where bioX is headquartered

Location

Headquarters

HQ city
Salem
HQ country
United States
HQ region
North America

Offices1 record

Markets served

bioX business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Process Engineering and Consulting Services: Provides bio-process engineering, single-use technology consulting, quality engineering, and methods development/analytical testing services on a project basis. Revenue generated through consulting engagements, feasibility studies, and technical advisory services.
  2. Early Phase CDMO Services: Contract development and manufacturing organization services including tech transfer from bench to pilot scale, process optimization, regulatory submission support, and agile manufacturing capabilities. Revenue generated through project-based manufacturing and development contracts.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

bioX product offering

Product offering

Core offering

bioX delivers integrated Bio-Process Engineering, Analytical Testing, Process Development, and Early Phase Contract Development and Manufacturing Organization (CDMO) services for the biopharmaceutical industry. The company operates a proprietary 14,000 sq/ft ISO-7 Applications Lab that runs USP/ASTM/ISO product release, physical/mechanical, biological, and chemical testing, as well as pilot-scale manufacturing feasibility campaigns. Services span Cell Banking through DP (Drug Product) bottling for advanced therapy, RNA, monoclonal antibody, ADC, exosome, microbiome, and ATMP developers.

Product overview

bioX is a biotech engineering, analytical testing, and Contract Development and Manufacturing Organization (CDMO) solutions provider. The company offers a portfolio of integrated services including Bio-Process Engineering and Consulting, Early Phase CDMO Services, a Pilot Scale and Applications Lab, Quality Engineering and Consulting, Strategic BioEngineering Services, Manufacturing Process Improvement, Automation Strategy Development, and Consulting and Training. The services are designed to work together as a single-source solutions provider, enabling clients to move from analytical development and methods qualification through feasibility testing to detail design and early phase manufacturing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bio-Process Engineering and Consulting Provides bio-process engineering, single-use technology program development, process and product development, bio-process applications testing, quality engineering, and methods development/analytical testing services for biotech and pharmaceutical clients.
  • Early Phase CDMO Services Contract Development and Manufacturing Organization services including tech transfer from bench to pilot scale, 21CFR compliant QMS for MBR and MFG compliance, in-house equipment supporting multiple manufacturing modalities and analytical testing, process optimization, regulatory submission and PPQ support, and agile manufacturing capabilities. Has a proven track record from Cell Banking through DP bottling.
  • Pilot Scale and Applications Lab A 14,000 sq/ft ISO-7 classified applications lab providing pilot scale manufacturing feasibility testing, comparison testing of similar unit operations, hold/stability testing, container closure testing, sterility program development, MTBF testing, spallation testing, mixing characterization, forced extraction, endotoxin testing, bioburden testing, particulate testing, and autoclave services.
  • Quality Engineering and Consulting Provides commissioning, qualification and validation (CQV), quality plan and systems development, shipper and shipping qualification, equipment and automation qualification, validation master planning, and user requirement specifications development for biotech and pharma manufacturing operations.
  • Strategic BioEngineering Services Provides owner's project management for capital project design and execution, project and process design lead/subject matter expertise, master planning for biotech and pharma, environmental sustainability planning, and Industry 4.0 strategic initiatives for digital transformation.
  • Manufacturing Process Improvement Analyzes current manufacturing processes and identifies areas for improvement to increase efficiency and reduce costs for biopharma manufacturing clients.
  • Automation Strategy Development Develops software solutions for embedded systems and control/automation systems to ensure product reliability and efficiency in biotech manufacturing operations.
  • Consulting and Training Provides comprehensive consulting and training services for process and product design, manufacturing process improvement, and technology transfer to biopharma client teams.

Quantifiable outcome

  • Reduced costs through agile manufacturing innovation
  • +1 more outcomes

Companies that use bioX

Customer profile

Segments8 records

Ideal customer profiles5 records

bioX technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

bioX partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

bioX competitors and assessment

Company assessment

Others

  • Cytiva: Danaher-owned bioprocess equipment and services supplier serving the same biotech manufacturing customers as bioX. An adjacent ecosystem participant rather than a direct CDMO competitor, but competes for SUT-related service and consulting budgets.

Direct peers

  • Tunnell Consulting: Biopharma-focused management and process consulting firm serving similar biotech clients on process improvement, tech transfer, and operational strategy. Most direct comparable to bioX on the consulting/engineering side rather than the CDMO side.
  • Forge Biologics: Gene therapy CDMO offering process development, analytical services, and cGMP manufacturing for AAV and other viral vectors. Closely comparable to bioX on cell/gene therapy focus and pilot-to-commercial pathway.
  • Resilience: National Resilience is a technology-focused biomanufacturing company offering end-to-end process development, analytical, and clinical manufacturing services for biologics, vaccines, and advanced therapies — directly comparable to bioX's early-phase CDMO offering.
  • Andelyn Biosciences: Specialist CDMO focused on cell and gene therapy development and manufacturing, including viral vectors and plasmid DNA. Overlaps with bioX's cell/gene therapy process development and early-phase CDMO services.
  • Curia (formerly AMRI): Contract development and manufacturing organization providing process development, analytical services, and small- and large-molecule manufacturing — overlapping with bioX's analytical testing and pilot-scale capabilities.
  • Center for Breakthrough Medicines: Specialized CGT and biologics CDMO offering process development, analytical testing, and manufacturing for cell, gene, and viral vector therapies. Directly comparable to bioX on integrated early-phase services.

Broad incumbents

  • Catalent: Global CDMO with substantial early-phase development and clinical manufacturing capabilities across biologics and cell/gene therapy. BioX directly competes in pilot-scale and tech-transfer work but Catalent offers far greater scale, multi-site footprint, and late-phase capacity.
  • Lonza: One of the world's largest CDMOs with deep biologics, cell, and gene therapy manufacturing capability. BioX competes at the early-phase / pilot-scale entry point; Lonza is the typical 'upstream' competitor clients eventually migrate to for commercial production.
  • WuXi Biologics: Global biologics CDMO with end-to-end discovery, development, and manufacturing capabilities including mAb and recombinant protein services. Competes with bioX for early-phase work but operates at vastly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

bioX social profiles

Digital presence

bioX compliance and trust

Trust signal

Compliance1 record

bioX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

bioX leadership team

Management profile

Number of profiles

Profiles1 record

bioX funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

bioX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bioX

What does bioX do?

bioX delivers integrated Bio-Process Engineering, Analytical Testing, Process Development, and Early Phase Contract Development and Manufacturing Organization (CDMO) services for the biopharmaceutical industry. The company operates a proprietary 14,000 sq/ft ISO-7 Applications Lab that runs USP/ASTM/ISO product release, physical/mechanical, biological, and chemical testing, as well as pilot-scale manufacturing feasibility campaigns. Services span Cell Banking through DP (Drug Product) bottling for advanced therapy, RNA, monoclonal antibody, ADC, exosome, microbiome, and ATMP developers.

Is bioX a public or private company?

bioX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was bioX founded?

bioX was founded in 2019. It employs 11 to 50 people.

Where is bioX based?

bioX is headquartered in Salem, United States, in the North America region.

How does bioX make money?

Two revenue lines are on record. Process Engineering and Consulting Services are the primary driver. The others are early Phase CDMO Services.

Who are bioX's main competitors?

Cytiva is listed as an others. Direct peers are Tunnell Consulting, Forge Biologics, Resilience, Andelyn Biosciences, Curia (formerly AMRI) and Center for Breakthrough Medicines. Broad incumbents are Catalent, Lonza and WuXi Biologics.

Does bioX have an API?

No public API is recorded for bioX.

What industry is bioX in?

bioX's product category is Biopharmaceutical Engineering & CDMO Services. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO, with a secondary code of HLAGABAF, mRNA/LNP & Nucleic Acid Therapeutics CDMO. Its NAICS code is 541714 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales